Eiger BioPharmaceuticals Inc

NASDAQ:EIGR   12:17:42 PM EDT
6.57
+0.22 (+3.46%)
Earnings Announcements

Eiger BioPharmaceuticals Reports Q1 Loss Per Share Of $0.64

Published: 05/05/2022 21:32 GMT
Eiger BioPharmaceuticals Inc (EIGR) - Eiger Biopharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update.
Q1 Loss per Share $0.64.
Revenue is expected to be $4.7 Million
Adjusted EPS is expected to be -$0.58

Next Quarter Revenue Guidance is expected to be $5.91 Million
Next Quarter EPS Guidance is expected to be -$0.55

More details on our Analysts Page.